Canadians will soon see a new oral quinolone called Factive

February 2007

Canadians will soon see a new oral quinolone called Factive.

Factive (gemifloxacin) is similar to Avelox (moxifloxacin) and Levaquin (levofloxacin)...often referred to as "respiratory quinolones."

It's approved for acute exacerbations of chronic bronchitis.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

More Canadian pharmacists will prescribe in the future
Osteoporosis whether proton pump inhibitors (omeprazole, etc) increase the risk for fractures
Osteoporosis Women are hearing that they can take a break from their oral bisphosphonate (Fosamax, etc)
Symbicort being used in a new "SMART" regimen (Symbicort Maintenance And Reliever Therapy)
Men's Health anticholinergics (Detrol, Ditropan, etc) for urinary symptoms in men with benign prostatic hyperplasia
Cardiology Patients are asking if their meds for Parkinson's or restless legs will cause heart trouble
Cardiology BOTH Plavix and aspirin for at least 12 months after getting a drug-eluting coronary stent
Infectious Diseases Canadians will soon see a new oral quinolone called Factive
Neurology & Pain Zytram XL (controlled-release tramadol) will be a new ONCE- daily option for pain relief in Canada
Dermatology New evidence is helping to clear up what works for rosacea
Interactions misconceptions about grapefruit juice interactions
Hormone Therapy controversy about bioidentical hormones
Substance Use Disorder dextromethorphan abuse in teens
Practice the significant new drugs approved by Health Canada in 2006